Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
ISS03 - Industry Supported Symposium: Non-Small Cell Lung Cancer: The Programmed Death-Ligand 1 (PD-L1) Receptor as a Target for Monotherapy and in Combination – Merck-Pfizer Alliance
- Type: Industry Supported Symposium
- Track:
- Presentations: 6
- Moderators:S. Popat
- Coordinates: 12/04/2016, 15:30 - 17:00, Hall C2
-
+
ISS03.01 - Welcome and Overview
15:30 - 15:45 | Author(s): S. Popat
- Abstract
No abstract available for this presentation
-
+
ISS03.02 - Anti-PD-L1 Monotherapy in Non-Small Cell Lung Cancer (NSCLC): Overview of the Trials Examining anti-PD-L1 Monotherapy in NSCLC
15:45 - 16:00 | Author(s): R.A. Juergens
- Abstract
No abstract available for this presentation
-
+
ISS03.03 - Anti-PD-L1 Combined with Other Agents in NSCLC: Combinations with non-Immunooncology Agents
16:00 - 16:15 | Author(s): J.E. Gray
- Abstract
No abstract available for this presentation
-
+
ISS03.04 - Anti-PD-L1 Combined with Other Agents in NSCLC: Immuno-Oncology Combinations
16:15 - 16:30 | Author(s): S.I. Rothschild
- Abstract
No abstract available for this presentation
-
+
ISS03.05 - Anti-PD-L1 Agents: Opportunities for Differentiation
16:30 - 16:45 | Author(s): H. Borghaei
- Abstract
No abstract available for this presentation
-
+
ISS03.06 - Summary, Questions and Close
16:45 - 17:00 | Author(s): S. Popat
- Abstract
No abstract available for this presentation
-
+
ED11 - Advanced NSCLC: State-of-the-Art Treatment
- Type: Education Session
- Track: Advanced NSCLC
- Presentations: 4
- Moderators:C. Manegold
- Coordinates: 12/07/2016, 11:00 - 12:30, Hall C8
-
+
ED11.01 - Systemic Therapy for Advanced Oncogene-Driven NSCLC
11:00 - 11:25 | Author(s): D.R. Gandara
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA16 - Novel Strategies in Targeted Therapy
- Type: Mini Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 12
- Moderators:G. Purkalne
- Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
-
+
MA16.03 - Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung Cancers
14:26 - 14:32 | Author(s): O. Gautschi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA22 - Novel Trials and Biomarkers in Malignant Pleural Mesothelioma
- Type: Oral Session
- Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 8
- Moderators:H. Pass
- Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 3
-
+
OA22.02 - Nintedanib plus Pemetrexed/Cisplatin in Patients with MPM: Phase II Findings from the Placebo-Controlled LUME-Meso Trial
14:30 - 14:40 | Author(s): F. Grosso
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.02a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 37
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02a-016 - Pooled Efficacy and Safety Data from Two Phase II Studies (NP28673 and NP28761) of Alectinib in ALK+ Non-Small-Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): J.C. Yang
- Abstract
Loading...
-
+
P3.02b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 126
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02b-046 - Afatinib Benefits Patients with Confirmed/Suspected EGFR Mutant NSCLC, Unsuitable for Chemotherapy (TIMELY Phase II Trial)
14:30 - 14:30 | Author(s): S. Popat
- Abstract
Loading...
-
+
P3.05 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Palliative Care/Ethics
- Presentations: 20
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.05-006 - Anxiolytic Effect of Acupuncture in a Phase II Study of Acupuncture and Morphine for Dyspnoea in Lung Cancer and Mesothelioma
14:30 - 14:30 | Author(s): A.R. Minchom
- Abstract
Loading...
